Funding for this research was provided by:
Medicinska Fakulteten, Lunds Universitet (ALFSKANE 446501)
Received: 2 October 2019
Accepted: 9 January 2020
First Online: 22 January 2020
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee in Stockholm, Sweden, and it was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Cagnotto G. has received consulting fee from Novartis and has no disclosures related to this paper.Compagno M. has received speaking fee from Abbvie and has no disclosures related to this paper.Willim M. and Nilsson JÅ. have no disclosures.Jacobsson L.T.H. has received lecture and consulting fees from Pfizer, Abbvie, Novartis, Eli-Lily, and Janssen.Saevarsdottir S. is a part-time employee of deCODE Genetics, working on research unrelated to this subject.Turesson C. has received consulting fees from Roche, speaking fees from Abbvie, Bristol Myers-Squibb, Pfizer, Roche, and an unrestricted grant for this study from Bristol Myers-Squibb.